Most studies assessing the plasma/serum concentration or tissue expression of eotaxins concern changes after treatment in the course of various allergic diseases (i.e., asthma, atopic dermatitis, eosinophilic esophagitis, and chronic rhinosinusitis). Here, CCL11 is linked to asthma.